Prime Therapeutics ranked No. 3 on Minnesota top private companies list

The Minneapolis/St. Paul Business Journal named Prime Therapeutics (Prime) to its annual list, Minnesota’s 100 Largest Private Companies. For fiscal year 2022, Prime earned the No. 3 position.

The Journal’s once yearly list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.

The full Minnesota’s 100 Largest Private Companies list is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.

About Prime Therapeutics + Magellan Rx

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit www.primetherapeutics.com and www.magellanrx.com, or follow us on Twitter at @Prime_PBM and @Magellan_Rx.

Prime Therapeutics ranked No. 3 on Minnesota top private companies list

About Prime Therapeutics + Magellan Rx

Related news

Prime, Magellan Rx Offer Value Plus to Help States Negotiate Value-Based Contracts for CGTs

Prime Together Foundation: Helping students achieve their dreams

Prime Together Foundation grant provides music therapy, joy for residents at Living Well Disability Services home